Kinases are reported to modulate the activity of NF-κB in glioma cell lines and pancreatic cancer cells through post-translational modification (PTM) of the NF-κB subunits (p65/p50) [166,167,168,169]. This evidence concerns the gene NFKB1 and central nervous system cancer.